---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-016979"
form_type: "8-K"
ticker: "PTIX"
cik: "0001022899"
company_name: "Protagenic Therapeutics, Inc.new"
filed_at: "2025-06-27T23:59:59+00:00"
generated_at: "2026-05-18T15:26:54.342962+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Protagenic Therapeutics declares rights offering at $0.01 per share to preserve ownership after Phytanix acquisition

## Summary
- Board authorized distribution of one Right per common share held as of July 7, 2025 record date.
- Each Right entitles holder to purchase 4.57 common shares at $0.01 per share, subject to stockholder approval.
- Rights become exercisable only after stockholder meeting approves Phytanix acquisition and share issuance; exercisable for up to 6 months.
- Rights initially trade with Common Stock, become separable after approval; Rights Agreement with Equiniti Trust Company.

## SEC filing metadata
- accession: 0001641172-25-016979
- form_type: 8-K
- ticker: PTIX
- cik: 0001022899
- company_name: Protagenic Therapeutics, Inc.new
- filed_at: 2025-06-27T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 3.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1022899/000164117225016979/0001641172-25-016979-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1022899/000164117225016979/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-016979
- JSON: https://secwatch.observer/filing/0001641172-25-016979.json
- Plain text: https://secwatch.observer/filing/0001641172-25-016979.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.